Skip to main content

Closed

MNKD: MannKind Corporation Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth+43.5% / yr

Operating margin3.7%

ROIC1.8%

Financially safe

Stretched

Debt / equity-7.38×

Interest coverage0.3×

Current ratio1.87×

MannKind Corporation

MNKDNASDAQ Global Market·USD·Closed

MannKind Corporation

MNKDNASDAQ·USD·Closed

$3.91

−4.87%

$3.91

−$0.20 (4.87%)

52W Range

39thpctl

Volume

0.91×avg

Mkt Cap

1.21BUSD

P/E

-53.2TTM

Div Yield

–ann

52W Range

39thpctl

Volume

0.91×avg

Market Cap

1.21BUSD

P/E Ratio

-53.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings